Magnetic resonance imaging evaluation of lipodystrophy in HIV-positive patients receiving highly active antiretroviral therapy

被引:2
作者
Eichler, K. [1 ]
Bickel, T. M. [2 ]
Klauke, S. [2 ]
Eisen, J. [1 ]
Vogl, T. J. [1 ]
Zangos, S. [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Diagnost & Intervent Radiol, D-60590 Frankfurt, Germany
[2] Infektiologikum, Frankfurt, Germany
关键词
HIV; AIDS; antiretroviral therapy; lipodystrophy; lipoatrophy; lipohypertrophy; VAT; magnetic resonance imaging; MRI; screening; viral disease; FAT DISTRIBUTION; INFECTED PATIENTS; COMPUTED-TOMOGRAPHY; METABOLIC-CHANGES; LIPOATROPHY;
D O I
10.1177/0956462414546916
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated retrospectively an automated method for the separate detection of subcutaneous and visceral fat in the abdominal region by magnetic resonance studies in HIV-positive patients on highly active antiretroviral therapy. The patients were divided into four different groups: lipoatrophy, lipohypertrophy, mixed and the control group. The use of software for the automated detection of abdominal compartment visceral adipose tissue (VAT), total adipose tissue (TAT) and subcutaneous adipose tissue (SAT) was compared to manual evaluation methods (fuzzy C-mean). The results of ROC analysis showed that the parameters, particularly the VAT, are better than the VAT/TAT and at identifying patients with the symptoms of abdominal fat accumulation. A sensitivity of 80.3% and a specificity of 79.5% resulted from a threshold VAT value of >87cm(2). Moreover, the manual evaluation method was shown to provide greater values for VAT and the VAT/TAT ratio than those given by the automated method. In the present study, a rapid MRI protocol for the detection and assessment of the course of lipodystrophy was presented and tested on a group of patients with signs of HALS, as well as on an antiretroviral naive control group.
引用
收藏
页码:582 / 589
页数:8
相关论文
共 12 条
[1]   Fat distribution in men with HIV infection [J].
Bacchetti, P ;
Gripshover, B ;
Grunfeld, C ;
Heymsfield, S ;
McCreath, H ;
Osmond, D ;
Saag, M ;
Scherzer, R ;
Shlipak, M ;
Tien, P .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (02) :121-131
[2]  
Benn P, 2003, HIV Med, V4, P325, DOI 10.1046/j.1468-1293.2003.00167.x
[3]   HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study [J].
Carr, A ;
Hudson, J ;
Chuah, J ;
Mallal, S ;
Law, M ;
Hoy, J ;
Doong, N ;
French, M ;
Smith, D ;
Cooper, DA .
AIDS, 2001, 15 (14) :1811-1822
[4]   Regional body fat distribution in HIV-infected patients with lipodystrophy [J].
Dinges, WL ;
Chen, DL ;
Snell, PG ;
Weatherall, PT ;
Peterson, DM ;
Garg, A .
JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) :15-25
[5]   Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome [J].
Kosmiski, LA ;
Kuritzkes, DR ;
Lichtenstein, KA ;
Glueck, DH ;
Gourley, PJ ;
Stamm, ER ;
Scherzinger, AL ;
Eckel, RH .
AIDS, 2001, 15 (15) :1993-2000
[6]   Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia [J].
Mallon, PWG ;
Wand, H ;
Law, M ;
Miller, J ;
Cooper, DA ;
Carr, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (02) :156-162
[7]   Single-slice computed tomography and anthropometric skinfold analysis for evaluation of facial lipoatrophy in HIV-infected patients [J].
Padilla, S ;
Gallego, JA ;
Masiá, M ;
Gutiérrez, F .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (12) :1848-1851
[8]   Fat distribution and metabolic changes in patients with HIV infection [J].
Safrin, S ;
Grunfeld, C .
AIDS, 1999, 13 (18) :2493-2505
[9]   Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study [J].
Saint-Marc, T ;
Partisani, M ;
Poizot-Martin, I ;
Rouviere, O ;
Bruno, F ;
Avellaneda, R ;
Lang, JM ;
Gastaut, JA ;
Touraine, JL .
AIDS, 2000, 14 (01) :37-49
[10]   Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy [J].
Savès, M ;
Raffi, F ;
Capeau, J ;
Rozenbaum, W ;
Ragnaud, JM ;
Perronne, C ;
Basdevant, A ;
Leport, C ;
Chêne, G .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) :1396-1405